AstraZeneca Plc

A vial and sryinge are seen in front of a displayed AstraZeneca logo in this illustration taken January 11, 2021. REUTERS/Dado Ruvic/Illustration/File Photo
Coronavirus chronicle

WHO insists AstraZeneca vaccine safe as jab faces new setbacks

UK-based AstraZeneca insisted its jab was safe, adding there is “no evidence” of higher blood clot risks

A vial and sryinge are seen in front of a displayed AstraZeneca logo in this illustration taken January 11, 2021. REUTERS/Dado Ruvic/Illustration/File Photo
Coronavirus chronicle

Germany approves AstraZeneca for over-65s

A healthcare worker prepares to administer a dose of the Oxford University-AstraZeneca vaccine, marketed by the Serum Institute of India (SII) as COVISHIELD, against the coronavirus disease (COVID-19), in Santiago, Dominican Republic February 17, 2021. REUTERS/Ricardo Rojas/File Photo
Coronavirus chronicle

UK to receive 10 million AstraZeneca Covid-19 vaccine doses from India's Serum Institute

The AstraZeneca logo is pictured outside the AstraZeneca office building in Brussels as part of the coronavirus disease (COVID-19) vaccination campaign, Belgium, January 28, 2021. REUTERS/Johanna Geron
Global Economy

AstraZeneca has sold its stake in Moderna for more than $1 billion: The Times

FILE PHOTO: A test tube labelled with the Vaccine is seen in front of an AstraZeneca logo in this illustration taken, September 9, 2020. REUTERS/Dado Ruvic/Illustration/File Photo
Coronavirus chronicle

AstraZeneca to miss second-quarter EU vaccine supply target by half

File Photo: A member of the medical staff holds a vial of the Oxford-AstraZeneca COVID-19 vaccine at the Foch hospital in Suresnes, near Paris, France, February 8, 2021. REUTERS/Benoit Tessier
Coronavirus chronicle

AstraZeneca vaccine could get WHO emergency approval by mid-February

File Photo: A member of the medical staff holds a vial of the Oxford-AstraZeneca COVID-19 vaccine at the Foch hospital in Suresnes, near Paris, France, February 8, 2021. REUTERS/Benoit Tessier
Coronavirus chronicle

Global health officials back AstraZeneca vaccine after South Africa study rings alarm

A vail of the Oxford-AstraZeneca Covid-19 vaccine is seen at Basingstoke Fire Station, in Basingstoke, Britain February 4, 2021. REUTERS/Peter Cziborra/File Photo
Coronavirus chronicle

UK says Astrazeneca vaccine prevents Covid-19 death as South Africa halts shots

Britain's Medicines and Healthcare products Regulatory Agency (MHRA) started an accelerated "rolling review" of the vaccine at the start of this month as data comes in on safety and efficacy. Photo: Reuters
Coronavirus chronicle

Oxford/AstraZeneca Covid shot less effective against South African variant: Study

A health department employee counts vials of the vaccine developed by Oxford/AstraZeneca as she prepares to pack them up before they are transported from the state storage to a regional one, during the coronavirus disease (Covid-19) pandemic, in Bhubaneswar, India, January 13, 2021. REUTERS/Danish Siddiqui
Coronavirus chronicle

Serum India’s Covishield part of Pakistan’s Covid-jab drive under vaccine alliance

An employee in personal protective equipment (PPE) removes vials of AstraZeneca's COVISHIELD, coronavirus disease (COVID-19) vaccine from a visual inspection machine inside a lab at Serum Institute of India Photo: Reuters/Francis Mascarenhas
Coronavirus chronicle

AstraZeneca to increase EU vaccine deliveries by 30 percent

FILE PHOTO: A test tube labelled with the Vaccine is seen in front of an AstraZeneca logo in this illustration taken, September 9, 2020. REUTERS/Dado Ruvic/Illustration/File Photo
Coronavirus chronicle

Italy agency cautious on AstraZeneca jab for over 55s

An employee in personal protective equipment (PPE) removes vials of AstraZeneca's COVISHIELD, coronavirus disease (COVID-19) vaccine from a visual inspection machine inside a lab at Serum Institute of India Photo: Reuters/Francis Mascarenhas
Coronavirus chronicle

Germany threatens legal action over vaccine delays